Search research articles
Contact Us
Filters
Showing results (951-960 of 1,011) with videos related to
Page
of 102
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Kidney International
|
August 13, 2003
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
Arlene B Chapman, Lisa M Guay-Woodford, Jared J Grantham, et al.
Journal of the American Heart Association
|
March 11, 2018
Genome Wide Association Study Identifies the <i>HMGCS2</i> Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients
Sonal Singh, Caitrin W McDonough, Yan Gong, et al.
Journal of the American Society of Nephrology : JASN
|
January 30, 2016
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease
Christina M Heyer, Jamie L Sundsbak, Kaleab Z Abebe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2020
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
Michael A Postow, Susan J Knox, Debra A Goldman, et al.
Kidney International
|
December 26, 2019
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease
Katharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, et al.
Science Translational Medicine
|
August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Ronglai Shen, Michael A Postow, Matthew Adamow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Gregory S Phillips, Jennifer Wu, Matthew D Hellmann, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2015
Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors
Ravi K Amaravadi, Kathryn E Hamilton, Xiaohong Ma, et al.
Page
of 102
Search research articles
Search
Showing results (951-960 of 1,011) with videos related to
Sort By:
Page
of 102
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Kidney International
|
August 13, 2003
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
Arlene B Chapman, Lisa M Guay-Woodford, Jared J Grantham, et al.
Journal of the American Heart Association
|
March 11, 2018
Genome Wide Association Study Identifies the <i>HMGCS2</i> Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients
Sonal Singh, Caitrin W McDonough, Yan Gong, et al.
Journal of the American Society of Nephrology : JASN
|
January 30, 2016
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease
Christina M Heyer, Jamie L Sundsbak, Kaleab Z Abebe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2020
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
Michael A Postow, Susan J Knox, Debra A Goldman, et al.
Kidney International
|
December 26, 2019
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease
Katharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, et al.
Science Translational Medicine
|
August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Ronglai Shen, Michael A Postow, Matthew Adamow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Gregory S Phillips, Jennifer Wu, Matthew D Hellmann, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2015
Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors
Ravi K Amaravadi, Kathryn E Hamilton, Xiaohong Ma, et al.
Page
of 102